AKT1 and pancreatic neoplasm: Notably, the phosphatidylinositol 3-kinase-protein kinase B (PI3K/AKT) pathway is frequently activated in pancreatic cancer (8), but its upstream regulatory mechanisms—particularly how ECM components trigger this pathway through membrane receptors such as integrins—have not been systematically analyzed.